SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-032733
Filing Date
2022-05-31
Accepted
2022-05-31 08:27:21
Documents
1
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4016
  Complete submission text file 0001209191-22-032733.txt   5369
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Issuer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 TECHNOLOGY SQUARE SUITE 300 CAMBRIDGE MA 02139
Business Address
Le Goff Corinne (Reporting) CIK: 0001840912 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40192 | Film No.: 22980637